TTY Biopharm (Taiwan) Today
4105 Stock | TWD 74.40 0.30 0.40% |
Performance0 of 100
| Odds Of DistressLess than 9
|
TTY Biopharm is selling for under 74.40 as of the 27th of November 2024; that is 0.40 percent increase since the beginning of the trading day. The stock's lowest day price was 74.0. TTY Biopharm has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for TTY Biopharm Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
TTY Biopharm Company Limited, together with its subsidiaries, produces various pharmaceuticals and chemical drugs in Taiwan and internationally. The company was founded in 1960 and is headquartered in Taipei City, Taiwan. TTY BIOPHARM is traded on Taiwan OTC Exchange in Taiwan. The company has 248.65 M outstanding shares. More on TTY Biopharm Co
Moving together with TTY Stock
Moving against TTY Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
TTY Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. TTY Biopharm's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding TTY Biopharm or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
TTY Biopharm Co (4105) is traded on Taiwan OTC Exchange in Taiwan and employs 31 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 19.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TTY Biopharm's market, we take the total number of its shares issued and multiply it by TTY Biopharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. TTY Biopharm operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 248.65 M outstanding shares.
TTY Biopharm Co has accumulated about 2.89 B in cash with 1.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.63.
Check TTY Biopharm Probability Of Bankruptcy
Ownership AllocationTTY Biopharm shows a total of 248.65 Million outstanding shares. TTY Biopharm maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check TTY Ownership Details
TTY Biopharm Risk Profiles
Although TTY Biopharm's alpha and beta are two of the key measurements used to evaluate TTY Biopharm's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 0.3199 | |||
Semi Deviation | 0.4313 | |||
Standard Deviation | 0.4541 | |||
Variance | 0.2062 |
TTY Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in TTY Biopharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
TTY Biopharm Corporate Management
Elected by the shareholders, the TTY Biopharm's board of directors comprises two types of representatives: TTY Biopharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TTY. The board's role is to monitor TTY Biopharm's management team and ensure that shareholders' interests are well served. TTY Biopharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TTY Biopharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
SiYuan Yang | VP | Profile | |
KuoChiang Chang | Corp CFO | Profile | |
ShuFen Huang | Chief Officer | Profile | |
WeiYing Yin | Director Department | Profile | |
JenYang Chang | Chief Officer | Profile | |
ShuWen Wang | Accounting Officer | Profile | |
Allen Chu | Head Unit | Profile |
Additional Tools for TTY Stock Analysis
When running TTY Biopharm's price analysis, check to measure TTY Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TTY Biopharm is operating at the current time. Most of TTY Biopharm's value examination focuses on studying past and present price action to predict the probability of TTY Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TTY Biopharm's price. Additionally, you may evaluate how the addition of TTY Biopharm to your portfolios can decrease your overall portfolio volatility.